Tyra Biosciences, Inc. (TYRA)

Tyra Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	61.95	91.97	58.01	251.21	302.18	15.22
Short-Term Investments	212.97	249.48	145.46	-	-	-
Cash & Short-Term Investments	274.92	341.44	203.47	251.21	302.18	15.22
Cash Growth	-23.66%	67.81%	-19.00%	-16.87%	1884.90%	13996.30%
Other Receivables	2.2	2	0.7	-	-	-
Receivables	2.2	2	0.7	-	-	-
Prepaid Expenses	4.09	4.02	7.5	6.08	1.88	0.06
Total Current Assets	281.22	347.46	211.67	257.29	304.06	15.28
Property, Plant & Equipment	7.05	7.72	8.15	3.54	2.09	0.47
Other Long-Term Assets	13.59	8.38	6.03	5.35	0.56	0.26
Total Assets	301.85	363.56	225.86	266.18	306.7	16.01
Accounts Payable	1.99	0.59	4.66	1.15	0.55	0.66
Accrued Expenses	13.43	13.59	10.39	4.42	2.86	1.05
Current Portion of Leases	0.46	0.41	0.28	0.14	0.2	0.14
Total Current Liabilities	15.88	14.59	15.33	5.7	3.62	1.86
Long-Term Leases	5.46	5.81	6.22	2.48	0.98	-
Other Long-Term Liabilities	-	0	0.05	0.17	0.37	0.14
Total Liabilities	21.34	20.41	21.6	8.35	4.96	2
Common Stock	0.01	0.01	0	0	0	-
Additional Paid-In Capital	617.49	593.69	368.71	353.52	342.1	0.44
Retained Earnings	-337.42	-251.31	-164.83	-95.7	-40.37	-14.08
Comprehensive Income & Other	0.44	0.77	0.38	-	-	-
Total Common Equity	280.51	343.15	204.26	257.83	301.74	-13.64
Shareholders' Equity	280.51	343.15	204.26	257.83	301.74	14.01
Total Liabilities & Equity	301.85	363.56	225.86	266.18	306.7	16.01
Total Debt	5.92	6.22	6.5	2.62	1.18	0.14
Net Cash (Debt)	269.01	335.22	196.97	248.59	301	15.08
Net Cash Growth	-23.97%	70.19%	-20.76%	-17.41%	1895.75%	-
Net Cash Per Share	4.53	5.86	4.61	5.94	21.84	9.78
Filing Date Shares Outstanding	53.37	53.09	52.52	42.43	41.11	1.83
Total Common Shares Outstanding	53.32	50.75	43.02	42.35	40.95	1.83
Working Capital	265.34	332.87	196.34	251.59	300.44	13.42
Book Value Per Share	5.26	6.76	4.75	6.09	7.37	-7.45
Tangible Book Value	280.51	343.15	204.26	257.83	301.74	-13.64
Tangible Book Value Per Share	5.26	6.76	4.75	6.09	7.37	-7.45
Machinery	-	2.46	2.03	1.38	1.06	0.34
Leasehold Improvements	-	0.47	0.4	0.16	0.14	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q